Wenande E, Hastrup A, Wiegell S, Philipsen P, Thomsen N, Demehri S
JAMA Dermatol. 2025; .
PMID: 40047786
PMC: 11886873.
DOI: 10.1001/jamadermatol.2025.0531.
Zhao H, Ushcatz I, Tadrous M, Aoki V, Chang A, Levell N
JAAD Int. 2024; 16:18-25.
PMID: 38764482
PMC: 11099316.
DOI: 10.1016/j.jdin.2024.03.013.
Holovach P, Hsu W, Fleischer A
J Clin Med. 2024; 13(1).
PMID: 38202208
PMC: 10779529.
DOI: 10.3390/jcm13010202.
Lindholm V, Pitkanen S, Schroder M, Hahtola S, Sahi H, Halme H
Acta Derm Venereol. 2021; 101(2):adv00404.
PMID: 33491093
PMC: 9366706.
DOI: 10.2340/00015555-3754.
Reinehr C, Bakos R
An Bras Dermatol. 2019; 94(6):637-657.
PMID: 31789244
PMC: 6939186.
DOI: 10.1016/j.abd.2019.10.004.
Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives.
Gameiro L, Tovo L, Sanches Junior J, Aprahamian I
An Bras Dermatol. 2019; 94(3):313-319.
PMID: 31365660
PMC: 6668952.
DOI: 10.1590/abd1806-4841.20197938.
Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
Noels E, Hollestein L, van Egmond S, Lugtenberg M, van Nistelrooij L, Bindels P
Br J Dermatol. 2019; 181(3):544-553.
PMID: 30636037
PMC: 6850060.
DOI: 10.1111/bjd.17632.
Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis.
Carbotti M, Coppola R, Zanframundo S, Devirgiliis V, Panasiti V
Biomed Res Int. 2018; 2018:4381019.
PMID: 30246021
PMC: 6136582.
DOI: 10.1155/2018/4381019.
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
Dirschka T, Ekanayake-Bohlig S, Dominicus R, Aschoff R, Herrera-Ceballos E, Botella-Estrada R
J Eur Acad Dermatol Venereol. 2018; 33(2):288-297.
PMID: 30022544
PMC: 6585804.
DOI: 10.1111/jdv.15185.
Validity and Reliability of the Dutch Adaptation of the Actinic Keratosis Quality of Life Questionnaire (AKQoL).
Vis K, Waalboer-Spuij R, Snels D, Hollestein L
Dermatology. 2018; 234(1-2):60-65.
PMID: 29909413
PMC: 6106137.
DOI: 10.1159/000489118.
Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial.
Siegel D, Tyring S, Nahm W, Osterdal M, Petersen A, Berman B
J Clin Aesthet Dermatol. 2018; 10(12):19-26.
PMID: 29399263
PMC: 5774900.
Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston W, Muller K, Novak B, Stromer K, Termeer C, Hammann U
J Eur Acad Dermatol Venereol. 2017; 32(7):1138-1146.
PMID: 29150868
PMC: 6032898.
DOI: 10.1111/jdv.14703.
Immunohistochemical Analysis of Cyclooxygenase-2 in Non-Melanocytic Skin Cancer: Correlation With Morphological Subtype and Histologic Grade.
Koyuncuer A
World J Oncol. 2017; 5(5-6):189-195.
PMID: 29147402
PMC: 5649766.
DOI: 10.14740/wjon869w.
High Patient Satisfaction with Daylight-Activated Methyl Aminolevulinate Cream in the Treatment of Multiple Actinic Keratoses: Results of an Observational Study in Australia.
See J, Gebauer K, Wu J, Manoharan S, Kerrouche N, Sullivan J
Dermatol Ther (Heidelb). 2017; 7(4):525-533.
PMID: 28905294
PMC: 5698198.
DOI: 10.1007/s13555-017-0199-9.
Label-free characterization of ultra violet-radiation-induced changes in skin fibroblasts with Raman spectroscopy and quantitative phase microscopy.
Singh S, Kang S, Kang J, So P, Dasari R, Yaqoob Z
Sci Rep. 2017; 7(1):10829.
PMID: 28883655
PMC: 5589874.
DOI: 10.1038/s41598-017-11091-6.
Efficacy of a Film-Forming Medical Device Containing Piroxicam and Sun Filters in the Treatment of Multiple Actinic Keratosis Lesions in a Subject with a History of Kaposi Sarcoma.
Scotti E, Deledda S, Milani M
Case Rep Dermatol. 2017; 8(3):254-261.
PMID: 28101017
PMC: 5216249.
DOI: 10.1159/000450723.
Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice.
Bettencourt M
J Clin Aesthet Dermatol. 2016; 9(3):20-4.
PMID: 27354884
PMC: 4896817.
Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study.
Emilio J, Schwartz M, Feldman E, Bieber A, Bienenfeld A, Jung M
Clin Cosmet Investig Dermatol. 2016; 9:89-93.
PMID: 27143946
PMC: 4845892.
DOI: 10.2147/CCID.S100999.
Molecular cancer prevention: Current status and future directions.
Colbert Maresso K, Tsai K, Brown P, Szabo E, Lippman S, Hawk E
CA Cancer J Clin. 2015; 65(5):345-83.
PMID: 26284997
PMC: 4820069.
DOI: 10.3322/caac.21287.
How to treat actinic keratosis? An update.
Costa C, Scalvenzi M, Ayala F, Fabbrocini G, Monfrecola G
J Dermatol Case Rep. 2015; 9(2):29-35.
PMID: 26236409
PMC: 4517799.
DOI: 10.3315/jdcr.2015.1199.